# IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/irccs-azienda-ospedliero-universitaria-di-bologna-policlinico-di-sant-orsola/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 57.6 |
| Citations | 2,139,555 |
| City | Bologna |
| Country | IT |
| Description | IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola is a research organisation in Bologna, IT. OpenAlex records 20,803 works and 2,139,555 citations for it. 2,642 researchers list it as their most recent affiliation. |
| Homepage | https://www.aosp.bo.it |
| OpenAlex ID | https://openalex.org/I4210097083 |
| Region | Emilia-Romagna |
| Researchers | 2,642 |
| ROR ID | https://ror.org/00t4vnv68 |
| Type | healthcare |
| Works | 20,803 |

## University papers

Showing 12 of 86.

- [Global vascular guidelines on the management of chronic limb-threatening ischemia](https://scholariq.org/papers/global-vascular-guidelines-on-the-management-of-chronic-limb-threatening/)
- [Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders](https://scholariq.org/papers/third-european-evidence-based-consensus-on-diagnosis-and-management-of/)
- [Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial](https://scholariq.org/papers/addition-of-rituximab-to-fludarabine-and-cyclophosphamide-in-patients-with/)
- [Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia](https://scholariq.org/papers/global-vascular-guidelines-on-the-management-of-chronic-limb-threatening-2/)
- [ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-crohn-s-disease-medical-treatment/)
- [EFSUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography. Part 1: Basic Principles and Technology](https://scholariq.org/papers/efsumb-guidelines-and-recommendations-on-the-clinical-use-of-ultrasound/)
- [ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-crohn-s-disease-surgical-treatment/)
- [Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study](https://scholariq.org/papers/risk-and-predictors-of-dementia-and-parkinsonism-in-idiopathic-rem-sleep/)
- [The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version)](https://scholariq.org/papers/the-efsumb-guidelines-and-recommendations-for-the-clinical-practice-of-contrast/)
- [ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-ulcerative-colitis-medical-treatment/)
- [Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy](https://scholariq.org/papers/prognostic-value-of-quantitative-contrast-enhanced-cardiovascular-magnetic/)
- [EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)](https://scholariq.org/papers/efsumb-guidelines-and-recommendations-on-the-clinical-use-of-liver-ultrasound/)

## University researchers

- [Mauro Gargiulo](https://scholariq.org/researchers/mauro-gargiulo/)
- [Eugenio Brunocilla](https://scholariq.org/researchers/eugenio-brunocilla/)
- [Elena Antelmi](https://scholariq.org/researchers/elena-antelmi/)
- [Leonardo Henry Eusebi](https://scholariq.org/researchers/leonardo-henry-eusebi/)
- [Enrico Gallitto](https://scholariq.org/researchers/enrico-gallitto/)

## University top topics

Showing 8 of 25.

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Aortic Disease and Treatment Approaches](https://scholariq.org/topics/aortic-disease-and-treatment-approaches/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)
- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.